Aristo Bio-tech An (ARISTO-SM.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-53.7%

₹39.84

vs ₹86.00 price

Levered DCF

₹199.99

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

3.01

Safe zone

Rating

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	7.11×	20.27×	14.02×	11.93×	27.94×	37.3×	39.7×	14.17×
P/B	1.15×	2.21×	1.62×	1.41×	2.69×	2.99×	3.26×	3.55×
P/S	0.14×	0.26×	0.22×	0.2×	0.24×	0.24×	0.2×	0.2×
EV / EBITDA	5.22×	10.54×	8.18×	6.96×	12.03×	14.32×	13.14×	7.93×
Gross margin	9.1%	7.0%	7.8%	10.0%	11.2%	10.2%	6.7%	8.6%
Operating margin	7.7%	5.7%	6.3%	7.4%	7.9%	8.0%	2.0%	3.1%
Net margin	2.0%	1.3%	1.6%	1.6%	0.9%	0.6%	0.5%	1.4%
Current ratio	1.26×	1.21×	1.26×	1.4×	1.23×	1.23×	1.18×	1.12×
Debt / equity	0.8×	0.59×	0.62×	0.75×	1.71×	1.66×	1.6×	1.28×
Interest coverage	0×	10.33×	0×	0×	0×	0×	0×	0×
Dividend yield	0.7%	0.4%	0.8%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	4.7%	8.4%	11.4%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	16.1%	10.9%	11.6%	11.8%	9.6%	8.0%	8.2%	25.0%
Return on invested capital	25.9%	22.7%	20.3%	22.9%	23.6%	27.1%	9.0%	16.9%
Return on assets	4.6%	2.9%	3.1%	3.6%	1.9%	1.3%	1.1%	3.1%
Free cash flow yield	10.7%	6.0%	1.9%	-16.1%	8.8%	0.7%	-2.0%	15.1%
Earnings yield	14.1%	4.9%	7.1%	8.4%	3.6%	2.7%	2.5%	7.1%
Enterprise value	₹838.3M	₹999.3M	₹700.6M	₹611.9M	₹629.4M	₹622M	₹592.4M	₹540.7M
Net debt / EBITDA	2.04×	1.85×	1.81×	2.12×	4.37×	5.1×	4.26×	2.05×
Cash conversion cycle (days)	46	28	39	49	46	56	61	18